Impact of elevated glycosylated hemoglobin on hospital outcome and 1 year survival of primary isolated coronary artery bypass grafting patients

IF 1.4 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS
Mona Ramadan , Ahmed Abdelgawad , Ahmed Elshemy , Emad Sarawy , Aly Emad , Mahmoud Mazen , Ahmed Abdel Aziz
{"title":"Impact of elevated glycosylated hemoglobin on hospital outcome and 1 year survival of primary isolated coronary artery bypass grafting patients","authors":"Mona Ramadan ,&nbsp;Ahmed Abdelgawad ,&nbsp;Ahmed Elshemy ,&nbsp;Emad Sarawy ,&nbsp;Aly Emad ,&nbsp;Mahmoud Mazen ,&nbsp;Ahmed Abdel Aziz","doi":"10.1016/j.ehj.2017.09.002","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><p>It is unknown whether adequacy of diabetic control, measured by hemoglobin A1c, is a predictor of adverse outcomes after coronary artery bypass grafting.</p></div><div><h3>Methods</h3><p>From December 2013 to November 2015, 80 consecutive patients underwent primary isolated CABG surgery at national heart institute, their data were prospectively collected and they were classified according to their HbA1c level into two groups, Group (A): Forty patients with fair glycemic control (HbA1c below or equal to 7%), Group (B): Forty patients with poor glycemic control (HbA1c above 7%). Hospital morbidity, mortality and one year survival were examined in both groups. Telephone conversation was used to call patients or their relatives to determine the one year survival and it was 100% complete. This study had gained the ethical approval from national heart institute ethical committee.</p></div><div><h3>Results</h3><p>In-hospital mortality for group A was 2.5% (one patient) and 7.5% (3 patients) for group B with no statistical significance. One year mortality was (5.13%) (2 patients for group A) and (8.11%) (3 patients) for group B with no statistical significance. As regard the morbidity there was no statistical significance between the two groups in the incidence of neurological complications whether stroke or coma, atrial fibrillation, postoperative myocardial infarction, low cardiac output syndrome, heart failure, renal failure, need for dialysis, deep sternal wound infection, and readmission. However, group B had lengthy hospital stay, lengthy ventilation hours, more respiratory complications, and more superficial wound infection with a statistical significance when compared to group A, P values were 0.003, 0.003, 0.038, 0.044 respectively.</p></div><div><h3>Conclusions</h3><p>This study showed that HbA1c is a good predictor of in-hospital morbidity. It worth devoting time and effort to decrease HbA1c level below 7% to decrease possible postoperative complications.</p></div>","PeriodicalId":44962,"journal":{"name":"Egyptian Heart Journal","volume":"70 2","pages":"Pages 113-118"},"PeriodicalIF":1.4000,"publicationDate":"2018-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.ehj.2017.09.002","citationCount":"13","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Egyptian Heart Journal","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1110260816301788","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 13

Abstract

Objective

It is unknown whether adequacy of diabetic control, measured by hemoglobin A1c, is a predictor of adverse outcomes after coronary artery bypass grafting.

Methods

From December 2013 to November 2015, 80 consecutive patients underwent primary isolated CABG surgery at national heart institute, their data were prospectively collected and they were classified according to their HbA1c level into two groups, Group (A): Forty patients with fair glycemic control (HbA1c below or equal to 7%), Group (B): Forty patients with poor glycemic control (HbA1c above 7%). Hospital morbidity, mortality and one year survival were examined in both groups. Telephone conversation was used to call patients or their relatives to determine the one year survival and it was 100% complete. This study had gained the ethical approval from national heart institute ethical committee.

Results

In-hospital mortality for group A was 2.5% (one patient) and 7.5% (3 patients) for group B with no statistical significance. One year mortality was (5.13%) (2 patients for group A) and (8.11%) (3 patients) for group B with no statistical significance. As regard the morbidity there was no statistical significance between the two groups in the incidence of neurological complications whether stroke or coma, atrial fibrillation, postoperative myocardial infarction, low cardiac output syndrome, heart failure, renal failure, need for dialysis, deep sternal wound infection, and readmission. However, group B had lengthy hospital stay, lengthy ventilation hours, more respiratory complications, and more superficial wound infection with a statistical significance when compared to group A, P values were 0.003, 0.003, 0.038, 0.044 respectively.

Conclusions

This study showed that HbA1c is a good predictor of in-hospital morbidity. It worth devoting time and effort to decrease HbA1c level below 7% to decrease possible postoperative complications.

糖化血红蛋白升高对初次离体冠状动脉旁路移植术患者住院结局和1年生存率的影响
目的目前尚不清楚糖化血红蛋白(A1c)是否可以作为冠状动脉搭桥术后不良预后的预测指标。方法2013年12月至2015年11月,在国家心脏研究所连续行原发性孤立性冠状动脉绕道手术的患者80例,前瞻性收集患者资料,根据患者HbA1c水平分为两组,A组:血糖控制良好(HbA1c低于或等于7%)的患者40例,B组:血糖控制不良(HbA1c高于7%)的患者40例。观察两组患者的住院发病率、死亡率和一年生存率。用电话交谈的方式给病人或他们的亲属打电话,以确定一年的生存率,这是100%完成的。本研究已获得国家心脏研究所伦理委员会的伦理批准。结果A组住院死亡率为2.5%(1例),B组为7.5%(3例),差异无统计学意义。A组1年死亡率为(5.13%)(2例),B组为(8.11%)(3例),差异无统计学意义。在发病率方面,两组在脑卒中或昏迷、心房颤动、术后心肌梗死、低心输出量综合征、心力衰竭、肾功能衰竭、透析需要、胸骨深创面感染、再入院等神经系统并发症的发生率方面差异无统计学意义。但B组患者住院时间长、通气时间长、呼吸系统并发症多、创面浅表感染多,与a组比较差异均有统计学意义,P值分别为0.003、0.003、0.038、0.044。结论:本研究表明HbA1c是院内发病率的良好预测指标。将HbA1c水平降至7%以下,以减少术后可能出现的并发症是值得投入时间和精力的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Egyptian Heart Journal
Egyptian Heart Journal CARDIAC & CARDIOVASCULAR SYSTEMS-
CiteScore
2.10
自引率
0.00%
发文量
82
审稿时长
9 weeks
期刊介绍: The Egyptian Heart Journal is the official journal of the Egyptian Society of Cardiology. It is an international journal that publishes peer-reviewed articles on all aspects of cardiovascular disease, including original clinical studies and translational investigations. The journal publishes research, review articles, case reports and commentary articles, as well as editorials interpreting and commenting on the research presented. In addition, it provides a forum for the exchange of information on all aspects of cardiovascular medicine, including educational issues.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信